Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
In Vivo (Athens, Greece)|June 23, 2022
The Modified Glasgow Prognostic Score and Prognostic Nutritional Index as Prognostic Markers in Patients With Metastatic Breast Cancer Treated With EribulinShinya Yamamoto, Shoko Adachi, Tomoko Wada, et al.
Surgery|March 16, 2013
Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burdenOmar M Rashid, Masayuki Nagahashi, Subramaniam Ramachandran, et al.
American Journal of Cancer Research|November 12, 2021
Conflicting roles of EGFR expression by subtypes in breast cancerMasanori Oshi, Shipra Gandhi, Yoshihisa Tokumaru, et al.
Annals of Surgery|July 1, 2024
Infiltration of Common Myeloid Progenitor (CMP) Cells is Associated With Less Aggressive Tumor Biology, Lower Risk of Brain Metastasis, Better Response to Immunotherapy, and Higher Patient Survival in Breast CancerMasanori Oshi, Rongrong Wu, Thaer Khoury, et al.
Breast Cancer Research : BCR|May 23, 2026
TP53 mutation is associated with shorter treatment duration with CDK4/6 inhibitors, but not with immune checkpoint inhibitors, in ER-positive/HER2-negative breast cancer: real-world perspectiveMasanori Oshi, Makoto Sugimori, Kei Kawashima, et al.
Breast Cancer (Tokyo, Japan)|February 20, 2025
The impact of axillary lymph-node dissection omission on adjuvant abemaciclib eligibility in HR-positive, HER2-negative breast cancer with positive sentinel lymph nodesKei Kawashima, Kazutaka Narui, Aya Nishikawa, et al.
Breast Cancer Research and Treatment|May 31, 2022
Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancerMasanori Oshi, Shipra Gandhi, Li Yan, et al.
World Journal of Oncology|November 29, 2023
Dramatic Improvement of Pulmonary Tumor Thrombotic Microangiopathy in a Breast Cancer Patient Treated With BevacizumabAki Kimura, Akimitsu Yamada, Masanori Oshi, et al.
Gland Surgery|July 13, 2023
Breast carcinoma with spontaneous regression after needle biopsy: a case report and literature reviewMahato Sasamoto, Akimitsu Yamada, Masanori Oshi, et al.
American Journal of Cancer Research|October 18, 2021
MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapyMasanori Oshi, Shipra Gandhi, Michelle R Huyser, et al.
Pageof 11